How to File a Derivative Suit in the Philippines: Why Minority Shareholders Have the Power to Sue Rogue Directors
Introduction: why derivative suits matter to minority shareholders
Philippine corporate law generally vests the power to sue in the board of directors, because the corporation is a separate juridical entity. But where directors or controlling shareholders are the alleged wrongdoers—or refuse to act despite a clear corporate injury—the law recognizes an equitable remedy: the derivative suit.
A derivative suit allows a minority shareholder to sue in the name and for the benefit of the corporation, to recover for harm done to the corporation itself. The Supreme Court consistently treats this as an exception grounded on equity and fiduciary accountability, and it is closely regulated to prevent harassment suits and to respect corporate decision-making.
Governing legal basis: where derivative suits come from
Derivative suits are not created by a single statutory provision. They are recognized by jurisprudence as a mechanism to enforce corporate causes of action when corporate managers will not act, and are regulated by the rules on intra-corporate controversies.
The Supreme Court has described a derivative action as a suit by a shareholder to enforce a corporate cause of action where the corporation is the injured party and the corporation is the real party in interest, while the suing stockholder is only a nominal party. This is explained in Bangko Sentral ng Pilipinas v. Campa, Jr., et al. (G.R. No. 185979, 2016) and reiterated in Metropolitan Bank & Trust Company v. Salazar Realty Corporation (G.R. No. 218738, 2022).
On the corporate governance side, the Revised Corporation Code also contains remedies that often intersect with derivative litigation—such as removal of directors and appraisal rights—both of which can affect whether a derivative suit is proper or premature. (Revised Corporation Code of the Philippines or R.A. No. 11232, effective 2019, Sec. 27 on removal of directors; Sec. 80 on appraisal right.)
What a derivative suit is (and is not)
A derivative suit is filed when the wrong is to the corporation—for example, diversion of corporate funds, self-dealing transactions that bleed corporate assets, or gross mismanagement that causes corporate losses. The relief sought ultimately belongs to the corporation.
Not every shareholder dispute is derivative. If the injury is personal to the stockholder (or to third parties), it is not a derivative suit and should proceed as an ordinary civil action, not as an intra-corporate case mislabeled as derivative. This distinction is emphasized in Bangko Sentral ng Pilipinas v. Campa, Jr., et al. (G.R. No. 185979, 2016).
Why minority shareholders have standing to sue “rogue directors”
The rationale is straightforward: if the board controls corporate litigation, but the board (or controlling group) is implicated in the wrongdoing, insisting that only the board may sue would leave the corporation without a remedy. Philippine jurisprudence allows a stockholder to sue derivatively “whenever the officials of the corporation refuse to sue, or are the ones to be sued, or hold control of the corporation.” (Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016.)
In this sense, a derivative suit is an accountability mechanism for breaches of fiduciary duty that injure the corporation, consistent with the Court’s view that derivative suits are grounded on equity. (Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Threshold requirements: what must exist before you file
Philippine jurisprudence requires strict compliance with requisites developed in case law and incorporated into the procedural rules for intra-corporate controversies. The Supreme Court traces these requisites to San Miguel Corporation v. Kahn and consistently applies them in later cases.
Requisites under jurisprudence (as repeatedly applied by the Supreme Court)
As summarized by the Court, the traditional requisites include:
1) The plaintiff must be a stockholder at the time of the act complained of (and typically at filing);
2) The plaintiff must have exhausted intra-corporate remedies by making a demand on the board for relief (or show that demand would be futile); and
3) The cause of action must belong to the corporation (i.e., the harm is to the corporation, not to the suing stockholder individually).
These were reiterated in Metropolitan Bank & Trust Company v. Salazar Realty Corporation (G.R. No. 218738, 2022) and discussed in Bangko Sentral ng Pilipinas v. Campa, Jr., et al. (G.R. No. 185979, 2016).
The demand requirement: exhaustion is substantive, not cosmetic
One of the most common reasons derivative complaints fail is an insufficient allegation of demand and exhaustion. The Supreme Court requires the complaint to allege with particularity the efforts made to obtain relief within the corporation, or why such efforts would be futile.
Ching, et al. v. Subic Bay Golf and Country Club, Inc., et al. (G.R. No. 174353, 2014) stresses that the requirement to exhaust intra-corporate remedies—and to plead the efforts with specificity—is a substantive prerequisite. Failure to comply may warrant dismissal.
Corporation must be impleaded: the real party in interest must be before the court
A derivative suit must include the corporation as a party, because the corporation is the real party in interest and must be bound by the judgment (including for res judicata purposes). The Supreme Court is explicit that impleading the corporation is a condition sine qua non. (Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016; Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Relationship with appraisal rights and other corporate remedies
Derivative suits are not meant to replace other remedies that the law already provides for dissenting shareholders. Where the act complained of gives rise to appraisal rights, the rules on derivative suits generally expect that appraisal is unavailable for the acts complained of, because appraisal is a distinct statutory exit remedy.
Under the Revised Corporation Code (R.A. No. 11232, 2019), appraisal rights may be exercised in specific instances such as certain amendments to the articles, sale of all or substantially all assets, merger or consolidation, and certain investments of corporate funds. (R.A. No. 11232, Sec. 80.)
Separately, corporate governance tools may address director misconduct without immediately resorting to litigation. For example, directors may be removed by the vote required under the Revised Corporation Code, subject to rules protecting minority representation. (R.A. No. 11232, Sec. 27.)
Where to file: intra-corporate nature and the proper court
The Supreme Court treats derivative suits as intra-corporate in nature and triable by the appropriate special commercial court. (Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Still, when a case is erroneously filed as an intra-corporate/derivative case but actually alleges injury not to the corporation, the Court has held that the remedy is not automatically dismissal; the case should be referred to the proper RTC branch with general jurisdiction, consistent with the approach cited in Bangko Sentral ng Pilipinas v. Campa, Jr., et al. (G.R. No. 185979, 2016).
How to file a derivative suit: a step-by-step outline
The exact filing strategy depends on the facts, corporate documents, and available evidence. As a general outline consistent with Supreme Court doctrine:
Step 1: confirm the injury is to the corporation (not merely personal)
Frame the wrongdoing as a corporate injury: loss of corporate funds, diversion of corporate opportunities, self-dealing causing corporate losses, or misapplication/waste of corporate assets. If the harm is personal (e.g., denial of a stockholder’s individual right), reassess whether a direct action is proper instead of a derivative suit. (Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016.)
Step 2: verify shareholder status and timing
Ensure the plaintiff is a stockholder at the time of the act complained of (and at filing). This is an eligibility requirement repeatedly recognized by the Court. (Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Step 3: make a written demand on the board (unless futile) and document it
Serve a written demand on the board requesting specific corporate action: investigation, recovery of funds, rescission of an unfair contract, filing of a case, or other relief. If demand would be futile because the alleged wrongdoers control the board, document facts showing control, conflict, or refusal patterns.
In the complaint, allege the demand and the corporation’s response (or the circumstances of futility) with particularity; mere general statements are risky. (Ching, et al. v. Subic Bay Golf and Country Club, Inc., et al., G.R. No. 174353, 2014; Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016.)
Step 4: consider whether appraisal rights or internal remedies are available
If the complaint revolves around corporate acts where appraisal rights apply (e.g., merger, sale of substantially all assets), assess whether appraisal is the correct remedy for the dissenting stockholder rather than a derivative suit. (R.A. No. 11232, Sec. 80.)
Also consider internal governance remedies like director removal where appropriate, noting that removal without cause cannot be used to deprive minority stockholders of representation rights. (R.A. No. 11232, Sec. 27.)
Step 5: draft the complaint as a derivative suit and implead the corporation
The pleading should clearly state it is brought derivatively on behalf of the corporation, allege the requisites, and implead the corporation to bind it to the result. The Supreme Court treats impleader of the corporation as indispensable in derivative litigation. (Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016; Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Step 6: file in the proper court and be ready for threshold challenges
Expect early motions challenging (a) whether the claim is truly corporate, (b) whether demand was made or properly pleaded, and (c) whether the corporation was properly impleaded. Courts and opposing parties scrutinize derivative suits because they can be misused as leverage in corporate disputes. (Ching, et al. v. Subic Bay Golf and Country Club, Inc., et al., G.R. No. 174353, 2014; Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Common fact patterns: when derivative suits are often appropriate
Examples that typically fit a derivative theory (depending on proof and corporate approvals):
• Directors approve a contract with their own affiliate on grossly disadvantageous terms, causing corporate losses.
• Corporate funds are diverted to officers’ personal accounts or used to pay for non-corporate expenses.
• Corporate property is transferred for inadequate consideration to a company controlled by the same directors.
• Management refuses to sue insiders despite an audit report showing irregular disbursements, and the board is controlled by those implicated.
Quick reference table: derivative suit vs. direct suit
| Point of comparison | Derivative suit | Direct suit |
|---|---|---|
| Who is injured? | Corporation | Stockholder personally (or a distinct personal right) |
| Who is the real party in interest? | Corporation (stockholder is nominal plaintiff) | Stockholder |
| Demand on the board | Required or must show futility; must be pleaded with particularity | Usually not a derivative-demand issue |
| Must the corporation be impleaded? | Yes, condition sine qua non | Not necessarily |
This distinction is discussed in Bangko Sentral ng Pilipinas v. Campa, Jr., et al. (G.R. No. 185979, 2016) and the nature/requirements of derivative suits are reiterated in Metropolitan Bank & Trust Company v. Salazar Realty Corporation (G.R. No. 218738, 2022).
Minority shareholder meeting rights and agenda items (related governance tool)
Sometimes the immediate objective is to compel corporate action internally before litigating—for example, to have the corporation authorize an investigation, to demand records, or to propose board action. SEC Memorandum Circular No. 14, series of 2020 recognizes the ability of shareholders (individually or collectively holding at least 5% of outstanding capital stock) to include items on the agenda of stockholders’ meetings, even after the filing of the Definitive Information Statement, subject to the circular’s requirements. (SEC MC No. 14, s.2020.)
This is not a substitute for a derivative suit, but it may help build the record on demand, refusal, or board/management posture—issues that become central once a derivative action is filed.
Drafting tips: allegations that often determine survival at the outset
Derivative suits are often won or lost at the pleading stage. Consider these drafting points drawn from Supreme Court rulings:
• State with detail how the corporation was harmed, and quantify losses where possible.
• Identify the corporate act/transaction complained of, the approving directors/officers, and the conflict of interest facts.
• Plead demand efforts with specificity (dates, recipients, resolutions, refusals), or plead concrete facts showing futility. (Ching, et al. v. Subic Bay Golf and Country Club, Inc., et al., G.R. No. 174353, 2014.)
• Implead the corporation and explain that recovery is for the corporation. (Bangko Sentral ng Pilipinas v. Campa, Jr., et al., G.R. No. 185979, 2016; Metropolitan Bank & Trust Company v. Salazar Realty Corporation, G.R. No. 218738, 2022.)
Final observations and recommendations
A derivative suit is a serious remedy: it empowers minority shareholders to enforce fiduciary accountability when insiders block corporate redress, but it is tightly policed to avoid abuse. Before filing, confirm that the injury is corporate, document the demand process (or futility), and ensure the corporation is impleaded so the judgment properly binds the real party in interest.
Where available and suitable, evaluate complementary corporate remedies under the Revised Corporation Code—such as director removal or appraisal rights—because courts expect parties to use appropriate corporate mechanisms rather than treat litigation as the first option. (R.A. No. 11232, Sec. 27 and Sec. 80.)
About Nicolas and De Vega Law Offices
Nicolas and de Vega Law Offices is a full-service law firm in the Philippines. You may visit us at the 16th Flr., Suite 1607 AIC Burgundy Empire Tower, ADB Ave., Ortigas Center, 1605 Pasig City, Metro Manila, Philippines. You may also call us at +632 84706126, +632 84706130, +632 84016392 or e-mail us at [email protected]. Visit our website https://ndvlaw.com.
